Friday, 19 April 2024
Odonate Therapeutics Inc.
NASDAQ : ODT
3.230 12 Nov 21 00:00 | Change: 0.00 | Open: 3.240 | High: 3.240 | Ask: 0.000 | Volume: 102,800 |
Change(%): 0.00 | Prev: 3.230 | Low: 3.195 | Bid: 0.000 | Avg vol: 0 |
13:11 | 28/2/18
GuruFocus.com
CEO of Odonate Therapeutics Inc (NASDAQ:ODT) Kevin C Tang bought 28,612 shares of ODT on 02/27/2018 at an average price of $27.42 a share.
more»
14:07 | 23/2/18
GuruFocus.com
CEO of Odonate Therapeutics Inc (NASDAQ:ODT) Kevin C Tang bought 39,083 shares of ODT on 02/22/2018 at an average price of $27.17 a share.
more»
02:07 | 15/2/18
Business Wire
SAN DIEGO--(BUSINESS WIRE)--Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced financial results for ...
more»
08:19 | 4/1/18
Frisco Fastball
Among 3 analysts covering Odonate Therapeutics (ODT), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. Odonate Therapeutics has $40 highest and $27 lowest target.
more»
But Odonate's stock isn't necessarily a buy, and investors may find better value elsewhere, the analyst said. Specifically, Goldman's $27 price target is based on a discounted cash flow model that assumes a 13-percent weighted average cost of capital ...
more»
There are currently no comments on this topic.
Be the first person to Add a Comment...
You must be a registered user to post a comment: REGISTER NOW
If you are already registered, please LOGIN NOW
|
Code | Last | Change |
COMP | 10,321 | 328 | | 3.08% |
DJI | 29,635 | 404 | | 1.34% |
SP500 | 3,583 | 87 | | 2.37% |
DAX | 12,438 | 82 | | 0.67% |
FTSE | 7,488 | 5 | | 0.07% |
NI225 | 22,420 | 408 | | 1.86% |
TWI | 67.27 | 0.00 | | 0.00% |